Immunology and Allergy Clinics of North America

Papers
(The TQCC of Immunology and Allergy Clinics of North America is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
ArticleCitations
Defining Common Variable Immunodeficiency Disorders in 202036
Allergic Rhinitis in Children and Adolescents33
Anaphylaxis and Mast Cell Disorders28
Global Climate Change and Pollen Aeroallergens27
Biologics for the Treatment of Allergic Rhinitis, Chronic Rhinosinusitis, and Nasal Polyposis23
The Role of Extreme Weather and Climate-Related Events on Asthma Outcomes22
Racial/Ethnic Differences in Food Allergy22
Dietary Management of Food Allergy21
Innate Immunity21
Biologics for the Treatment of Allergic Conditions: Eosinophil Disorders18
IKAROS Family Zinc Finger 1–Associated Diseases in Primary Immunodeficiency Patients18
Chronic Lung Disease in Primary Antibody Deficiency16
Genetics of Food Allergy15
Air Pollution Effects in Allergies and Asthma14
Targeting Mast Cells with Biologics14
Climate Change and Pollen Allergy in India and South Asia14
Skin Testing Approaches for Immediate and Delayed Hypersensitivity Reactions12
Biologics for Atopic Dermatitis12
Biologics and Novel Therapies for Food Allergy12
The Impact of Climate Change on Pollen Season and Allergic Sensitization to Pollens12
Climate Change, Air Pollution, and Biodiversity in Asia Pacific and Impact on Respiratory Allergies11
The Infant Microbiome and Its Impact on Development of Food Allergy10
The Role of Smoking in Asthma and Chronic Obstructive Pulmonary Disease Overlap10
Contact Urticaria10
Monoclonal Antibodies (Biologics) for Allergic Rhinitis, Asthma, and Atopic Dermatitis During Pregnancy and Lactation9
The Who, What, Where, When, Why, and How of Drug Desensitization9
Biologics for the Treatments of Allergic Conditions9
Anaphylaxis9
Asplenia and Hyposplenism9
New Insights and Treatments in Atopic Dermatitis8
Mas-Related G Protein–Coupled Receptor-X2 and Its Role in Non-immunoglobulin E–Mediated Drug Hypersensitivity8
Allergy to Radiocontrast Dye8
Perioperative Anaphylaxis8
Immune-Related Adverse Drug Reactions and Immunologically Mediated Drug Hypersensitivity8
Precision Therapy for the Treatment of Primary Immunodysregulatory Diseases8
Biologics and Allergy Immunotherapy in the Treatment of Allergic Diseases8
Hemophagocytic Lymphohistiocytosis8
Psychosocial Aspects of Food Allergy8
Innate Immune Regulation of Dermatitis8
Insect Migration and Changes in Venom Allergy due to Climate Change7
Climate Change Factors and the Aerobiology Effect7
Advances in the Pathomechanisms of Delayed Drug Hypersensitivity7
Pharmacogenomics of Drug Hypersensitivity7
Anaphylaxis7
Phenotypes of Asthma–Chronic Obstructive Pulmonary Disease Overlap7
Recognizing Drug Hypersensitivity in Pigmented Skin7
Effect of Climate Change on Allergenic Airborne Pollen in Japan7
The Unmet Needs of Patients with Food Allergies7
Pathophysiology of Immunologic and Nonimmunologic Systemic Reactions Including Anaphylaxis6
Pediatric Drug Allergy6
Diagnosis and Management of Food Allergy6
Allergenic Pollen Season Variations in the Past Two Decades Under Changing Climate in the United States6
The Importance of Primary Immune Deficiency Registries6
Management of Mediator Symptoms, Allergy, and Anaphylaxis in Mastocytosis6
Management of Anaphylaxis6
Systemic Allergic Reactions and Anaphylaxis Associated with Allergen Immunotherapy6
Vaccines in Patients with Primary Immune Deficiency6
Pediatric Allergic Contact Dermatitis6
Anaphylaxis to Excipients in Current Clinical Practice6
Climate Change and Extreme Weather Events in Australia5
Anaphylaxis5
Mimics of Dermatitis5
Asthma-Chronic Obstructive Pulmonary Disease Overlap5
Biologics for the Treatment of Food Allergies5
The Use of Electronic Health Records to Study Drug-Induced Hypersensitivity Reactions from 2000 to 20215
Newborn Screening for Severe Combined Immunodeficiency5
Drug Hypersensitivity Reactions5
Eosinophilic Esophagitis5
Anaphylaxis in Children and Adolescents5
Biologic Agents for the Treatment of Anaphylaxis5
Sarcoidosis5
Viral Infections and Wheezing in Preschool Children5
Recognition and Management of Food Allergy and Anaphylaxis in the School and Community Setting4
Occupational Interstitial Lung Diseases4
Ozone in the Development of Pediatric Asthma and Atopic Disease4
Hypersensitivity Reactions and Immune-Related Adverse Events to Immune Checkpoint Inhibitors: Approaches, Mechanisms, and Models4
Drug and Venom Allergy in Mastocytosis4
World Health Organization Classification and Diagnosis of Mastocytosis4
Eosinophilic Lung Diseases4
Current and Potential Biologic Drugs for the Treatment of Chronic Urticaria4
A Risk-Based Approach to Penicillin Allergy4
Tackling Food Allergy in Infancy4
Forecast for Pollen Allergy4
Anaphylaxis to Stinging Insect Venom4
0.043890953063965